|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | (2013.01) |
| A61K 31/485 | (2006.01) | ||
| A61K 31/593 | (2006.01) | ||
| A61K 31/485 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/593 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/55511 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61K 39/39 | (2013.01) | ||
| C07D 489/08 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 2994137 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14725506.1 |
| Europos patento paraiškos padavimo data | 2014-05-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2014/051439 |
| Data | 2014-05-12 |
| (87) | Numeris | WO 2014/181131 |
| Data | 2014-11-13 |
| (30) | Numeris | Data | Šalis |
| 201308440 | 2013-05-10 | GB |
| (72) |
DALGLEISH, Angus , GB
ALLEN, Rachel , GB
|
| (73) |
LDN Pharma Limited ,
45 Gresham Street, London EC2V 7BG,
GB
|
| (54) | TREATMENT OF CANCER WITH NALTREXONE |
| TREATMENT OF CANCER WITH NALTREXONE |